On June 16, 2022, NeoGenomics Inc. (NASDAQ: NEO) opened at $7.18, lower -6.12% from the last session. During the day, the shares moved up to $7.18 and dropped to $6.855 before settling in for the closing price of $7.52. Price fluctuations for NEO have ranged from $6.85 to $54.74 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Healthcare Sector giant saw their annual sales surged by 15.90% over the last five years. Company’s average yearly earnings per share was noted -286.40% at the time writing. With a float of $121.48 million, this company’s outstanding shares have now reached $123.63 million.
The firm has a total of 2000 workers. Let’s measure their productivity.
NeoGenomics Inc. (NEO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of NeoGenomics Inc. is 1.30%, while institutional ownership is 91.90%. The most recent insider transaction that took place on Mar 07, was worth 58,693. In this transaction Chief Financial Officer of this company sold 3,209 shares at a rate of $18.29, taking the stock ownership to the 98,516 shares. Before that another transaction happened on Dec 21, when Company’s Chief Financial Officer sold 1,846 for $35.00, making the entire transaction worth $64,610. This insider now owns 11,689 shares in total.
NeoGenomics Inc. (NEO) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.2 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.23) by $0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -286.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.30% during the next five years compared to 29.40% growth over the previous five years of trading.
NeoGenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
Check out the current performance indicators for NeoGenomics Inc. (NEO). In the past quarter, the stock posted a quick ratio of 7.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of NeoGenomics Inc. (NEO)
Analysing the last 5-days average volume posted by the [NeoGenomics Inc., NEO], we can find that recorded value of 2.07 million was better than the volume posted last year of 1.92 million. As of the previous 9 days, the stock’s Stochastic %D was 19.93%. Additionally, its Average True Range was 0.70.
During the past 100 days, NeoGenomics Inc.’s (NEO) raw stochastic average was set at 1.24%, which indicates a significant decrease from 10.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.97% in the past 14 days, which was lower than the 106.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.58, while its 200-day Moving Average is $26.81. Now, the first resistance to watch is $7.21. This is followed by the second major resistance level at $7.36. The third major resistance level sits at $7.53. If the price goes on to break the first support level at $6.88, it is likely to go to the next support level at $6.71. Now, if the price goes above the second support level, the third support stands at $6.56.
NeoGenomics Inc. (NASDAQ: NEO) Key Stats
There are currently 124,758K shares outstanding in the company with a market cap of 925.28 million. Presently, the company’s annual sales total 484,330 K according to its annual income of -8,350 K. Last quarter, the company’s sales amounted to 117,170 K and its income totaled -49,410 K.